Skip to content

Clinical trials

Intermittent Claudication trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intermittent Claudication Country / region: United States Clear all

118 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20037
20044
20055
20068
20074
20086
20098
20103
20115
20124
20133
20147
20158
20164
20176
20184
20194
20201
20213
20225
20233
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79
Recruiting13
Unknown status12
Terminated8
Withdrawn3
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genovate Biotechnology Co., Ltd.,5
National Heart, Lung, and Blood Institute (NHLBI)5
Northwestern University5
Abbott Medical Devices4
University of California, San Francisco4
University of Minnesota4
University of Oklahoma4
Medtronic Endovascular3
ARCA Biopharma, Inc.2
Boston Scientific Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intermittent Claudication118
Peripheral Arterial Disease93
Peripheral Vascular Diseases37
Atherosclerosis20
Chronic Limb-Threatening Ischemia9
Arterial Occlusive Diseases8
Cardiovascular Diseases6
Vascular Diseases4
Mobility Limitation3
Thrombosis3

Trials

Showing 1 to 25 of 118. Each trial links to its page on Pharma Observatory.

18 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.